- Personal FinanceCompare Online BrokersTop StocksAlternative Investing
- CryptoGet StartedNFTs
Hoth Therapeutics (NASDAQ:HOTH), Quotes and News Summary
Hoth Therapeutics (NASDAQ: HOTH)
Earnings
see more| Q2 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2022-08-19 | ||||||
| REV | |||||||
| Q1 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.110 | ||||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
Hoth Therapeutics Questions & Answers
You can purchase shares of Hoth Therapeutics (NASDAQ: HOTH) through any online brokerage.
Other companies in Hoth Therapeutics’s space includes: Cingulate (NASDAQ:CING), Graybug Vision (NASDAQ:GRAY), Dermata Therapeutics (NASDAQ:DRMA), Baudax Bio (NASDAQ:BXRX) and Kiora Pharmaceuticals (NASDAQ:KPRX).
The latest price target for Hoth Therapeutics (NASDAQ: HOTH) was reported by EF Hutton on Thursday, March 31, 2022. The analyst firm set a price target for 2.50 expecting HOTH to rise to within 12 months (a possible 431.91% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Hoth Therapeutics (NASDAQ: HOTH) is $0.47 last updated August 5, 2022, 8:00 PM UTC.
There are no upcoming dividends for Hoth Therapeutics.
Hoth Therapeutics’s Q2 earnings are confirmed for Friday, August 19, 2022.
There is no upcoming split for Hoth Therapeutics.
Hoth Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.